Skip Navigation


JAC Advance Access originally published online on March 13, 2006
Journal of Antimicrobial Chemotherapy 2006 57(5):803-805; doi:10.1093/jac/dkl092
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/5/803    most recent
dkl092v2
dkl092v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lee, P. K.
Right arrow Articles by Nettles, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, P. K.
Right arrow Articles by Nettles, R. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Leading article

HIV-1 viral load blips are of limited clinical significance

Patricia K. Lee1,{dagger}, Tara L. Kieffer1,{ddagger}, Robert F. Siliciano1,2 and Richard E. Nettles1,*

1 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2 Howard Hughes Medical Institute, Baltimore, MD, USA

* Correspondence address. Bristol-Myers Squibb, MS E12-16 PO Box 4000, Princeton, NJ 08543, USA. Tel: +1-609-252-3719; Fax: +1-609-252-7034; E-mail: Richard.Nettles{at}BMS.com

Many patients on highly active antiretroviral therapy (HAART) who achieve undetectable HIV-1 RNA levels experience transient episodes of detectable viraemia or blips, suggesting there is incomplete suppression of viral replication. This raises concern that drug resistance mutations could develop and cause eventual treatment failure. However, data from recent studies indicate that most blips are actually random biological and statistical variations around a mean viral load below detectable levels (<50 copies/mL) or due to false elevations of viral load from laboratory processing artefacts. Blips are not typically associated with the development of resistance mutations and most importantly are not associated with virological or clinical failure of previously adequate HAART.

Keywords: HIV , genotypes , HAART , drug resistance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Int J STD AIDSHome page
S M Casserly, G R Scott, and M MacDougall
General practitioner involvement and patient outcomes in HIV management
Int J STD AIDS, July 1, 2009; 20(7): 503 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Int J STD AIDSHome page
M R Jordan, H La, H D Nguyen, H Sheehan, T T M Lien, D V Duong, J Hellinger, C Wanke, and A M Tang
Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam
Int J STD AIDS, June 1, 2009; 20(6): 418 - 422.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. Garcia-Gasco, I. Maida, F. Blanco, P. Barreiro, L. Martin-Carbonero, E. Vispo, J. Gonzalez-Lahoz, and V. Soriano
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome
J. Antimicrob. Chemother., March 1, 2008; 61(3): 699 - 704.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.